MOL MED REP - Molecular medicine reports
Publications
- 2016
Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancer
Lebok, P., Huber, J., Burandt, E-C., Lebeau, A., Marx, A. H., Terracciano, L., Heilenkötter, U., Jänicke, F., Müller, V., Paluchowski, P., Geist, S., Wilke, C., Simon, R., Sauter, G. & Quaas, A., 08.2016, In: MOL MED REP. 14, 2, p. 1443-50 8 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2008
Rechallenge with temozolomide with different scheduling is effective in recurrent malignant gliomas.
Strik, H. M., Buhk, J. H., Wrede, A., Hoffmann, A. L., Bock, H. C., Christmann, M. & Kaina, B., 2008, In: MOL MED REP. 1, 6, p. 863-867 6.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review